A pragmatic utility function to describe the risk-benefit composite of opioid and non-opioid analgesic medication

Anne Olesen, Suzanne Broens, Soren Olesen, Marieke Niesters, Monique van Velzen, Asbjorn Drewes, Albert Dahan, Erik Olofsen

Research output: Contribution to journalJournal articleResearchpeer-review

8 Citations (Scopus)

Abstract

It is not straightforward to simultaneously evaluate the beneficial and harmful effects of pain management, since different drugs may possess different analgesia and adverse effect profiles. Utility functions, derived from the pharmacokinetics and pharmacodynamics of individual outcome parameters, have been constructed to address this problem. Here, we construct "pragmatic" utility functions based on measurements of benefit and harm, but without making assumptions about the underlying pharmacokinetics and pharmacodynamics. Using data from two previous studies, utility functions were designed by estimating the probability of occurrence of benefit and harm and combining these into one function. Study 1 was a clinical trial on the effect of oral pregabalin on pain relief in chronic pancreatitis patients, with endpoint analgesia and dizziness monitored for 21 days. Study 2 was an experimental study on the effect of intravenous fentanyl on antinociception and respiratory depression in healthy volunteers. From study 1, the utility function was negative the first week of treatment, indicative of the greater probability of dizziness than analgesia, but positive thereafter. From study 2, the utility function showed a nadir 30 minutes after dosing, after which the probability function slowly increased toward zero. A pragmatic utility function based on the probability of two binary outcomes, analgesia and adverse effect, was successfully constructed using data from the two previous studies. The results yielded valuable insights into the utility of treatment and may be highly educative for physicians and potentially used in development of potent analgesics without serious side effects.

Original languageEnglish
JournalThe Journal of Pharmacology and Experimental Therapeutics
Volume371
Issue number2
Pages (from-to)416-421
Number of pages6
ISSN0022-3565
DOIs
Publication statusPublished - 1 Nov 2019

Bibliographical note

Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Fingerprint

Dive into the research topics of 'A pragmatic utility function to describe the risk-benefit composite of opioid and non-opioid analgesic medication'. Together they form a unique fingerprint.

Cite this